PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 164 filers reported holding PRECIGEN INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,292 | +23.5% | 57,248 | 0.0% | 0.00% | – |
| Q2 2023 | $65,835 | -20.2% | 57,248 | -26.4% | 0.00% | – |
| Q1 2023 | $82,504 | +31.5% | 77,834 | +88.5% | 0.00% | – |
| Q4 2022 | $62,754 | -27.0% | 41,285 | +1.7% | 0.00% | – |
| Q3 2022 | $86,000 | +36.5% | 40,610 | -14.2% | 0.00% | – |
| Q2 2022 | $63,000 | -44.7% | 47,353 | -12.1% | 0.00% | – |
| Q1 2022 | $114,000 | -49.3% | 53,872 | -10.9% | 0.00% | – |
| Q4 2021 | $225,000 | -21.3% | 60,488 | +5.3% | 0.00% | – |
| Q3 2021 | $286,000 | -25.9% | 57,435 | -3.0% | 0.00% | – |
| Q2 2021 | $386,000 | +24.1% | 59,193 | +30.9% | 0.00% | – |
| Q1 2021 | $311,000 | -38.2% | 45,213 | -8.4% | 0.00% | – |
| Q4 2020 | $503,000 | +182.6% | 49,335 | -3.2% | 0.00% | – |
| Q3 2020 | $178,000 | -11.9% | 50,983 | +25.8% | 0.00% | – |
| Q2 2020 | $202,000 | +152.5% | 40,520 | +73.3% | 0.00% | – |
| Q1 2020 | $80,000 | – | 23,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |